Tower Research Capital »

Nkgen Biotech shares owned by Tower Research Capital

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.2k 3.8k 1.89

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Home Depot (HD)

View all positions for Tower Research Capital

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech